What is the treatment for Stevens Johnson syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Stevens-Johnson Syndrome

Supportive care is the cornerstone of management for Stevens-Johnson syndrome (SJS), with immediate discontinuation of any potential culprit drug as the first and most critical step. 1

Initial Management

  • Immediately discontinue any suspected causative medication 1
  • Assess severity using SCORTEN to predict mortality risk 2
  • Transfer to a specialized care center with experience managing SJS/TEN, preferably a burn unit or ICU for patients with >10% body surface area epidermal detachment 2
  • Barrier nursing in a temperature-controlled room (25-28°C) on a pressure-relieving mattress 2

Multidisciplinary Team Approach

  • Treatment should involve specialists from dermatology, intensive care, ophthalmology, and specialist skincare nursing 2
  • Additional clinical input may be required from respiratory medicine, gastroenterology, gynecology, urology, oral medicine, microbiology, pain team, dietetics, physiotherapy and pharmacy based on organ involvement 2

Skin Management

  • Gentle skin handling to minimize shearing forces and prevent further epidermal detachment 2
  • Frequent application of bland emollients to support barrier function and reduce transcutaneous water loss 2
  • Appropriate dressings on exposed dermis to reduce fluid and protein loss, limit microbial colonization, control pain, and accelerate re-epithelialization 2
  • Conservative approach is generally preferred, but surgical debridement may be considered in cases of clinical deterioration, extension of epidermal detachment, local sepsis, or delayed healing 2

Mucosal Management

Ocular Care

  • Early ophthalmology consultation for all patients with ocular involvement 1
  • Frequent lubrication with preservative-free artificial tears and lubricating ointments 1
  • Daily examination for symblepharon formation with lysis of adhesions to prevent permanent scarring 1
  • Topical antibiotics when corneal fluorescein staining or ulceration is present 1
  • Amniotic membrane transplant may be needed for severe eye disease 2

Oral Care

  • Anti-inflammatory oral rinses containing benzydamine hydrochloride every 3 hours, particularly before eating 1
  • Antiseptic oral rinses twice daily 1
  • Topical anesthetics for severe oral discomfort 1
  • Monitor for and treat secondary infections 1

Urogenital Care

  • Urinary catheterization when urogenital involvement causes dysuria or retention 1
  • Regular examination of urogenital tract during acute illness 1
  • White soft paraffin ointment applied to urogenital skin and mucosae every 4 hours 1
  • Consider vaginal dilators to prevent vaginal synechiae formation 1

Fluid and Nutritional Management

  • Careful fluid resuscitation to prevent end-organ hypoperfusion while avoiding fluid overload 1
  • Monitor fluid balance with regular assessment of vital signs, urine output, and electrolytes 1
  • Maintain nutrition through appropriate feeding strategies 3

Infection Prevention and Management

  • Monitor for signs of infection rather than using prophylactic antibiotics, which may increase skin colonization with resistant organisms 2
  • Regular skin swabs for culture to detect predominant organisms 1
  • Targeted antimicrobial therapy only when clinical signs of infection are present 2

Systemic Therapy Options

  • Evidence for systemic therapies is limited and controversial 2
  • Systemic corticosteroids may be beneficial if started early (within 72 hours), but evidence is conflicting 2, 1
  • Cyclosporin has shown some benefit in adults according to meta-analysis data 2
  • Intravenous immunoglobulin (IVIG) has been used but with inconsistent results 2
  • TNF inhibitors (etanercept) may reduce mortality compared to corticosteroids, but evidence is limited 4

Psychological Support

  • Constant psychological support for both patient and nursing staff is necessary 3
  • Education and reassurance should be as much a part of the treatment process as drug therapy 3

Common Pitfalls to Avoid

  • Delayed recognition and treatment significantly increases mortality risk 2
  • Indiscriminate use of prophylactic antibiotics may increase skin colonization with resistant organisms 2
  • Overaggressive fluid resuscitation can lead to pulmonary, cutaneous, and intestinal edema 1
  • Failure to involve appropriate specialists early, particularly ophthalmology, can lead to permanent sequelae 1
  • Continued use of the culprit medication will worsen the condition and increase mortality 1

Prognosis and Follow-up

  • Mortality rates for SJS range from 1-5% and 25-35% for TEN 5
  • More than 50% of TEN survivors may experience long-term lower quality of life and reduced life expectancy 5
  • Regular follow-up with dermatology, ophthalmology, and other involved specialists is essential to manage long-term sequelae 6

References

Guideline

Treatment of Stevens-Johnson Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Stevens-Johnson syndrome: a review of the literature.

Journal of the National Medical Association, 1988

Research

Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Clinical reviews in allergy & immunology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.